Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Cornerstone Health Care, PA
- Target Recruit Count
- 43
- Registration Number
- NCT02167035
- Locations
- 🇺🇸
Cornerstone Health Care, High Point, North Carolina, United States
NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness
Phase 4
Completed
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2014-01-29
- Lead Sponsor
- Cornerstone Health Care, PA
- Target Recruit Count
- 37
- Registration Number
- NCT01591551
- Locations
- 🇺🇸
South Shore Neurologic Associates, Patchogue, New York, United States
🇺🇸Cornerstone Neurology, High Point, North Carolina, United States
🇺🇸Providence Brain Institute, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath